Drotrecogin alfa: a new approach in the treatment of severe sepsis

By Vincent Jean-Louis  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 6, 2002-08 ,pp. : 659-664

Informa Healthcare

Access to resources Recommend Favorite

Agalsidase alfa for the treatment of Fabry disease: new data on clinical efficacy and safety

By Beck Michael  

Expert Opinion on Biological Therapy, Vol. 9, Iss. 2, 2009-02 ,pp. : 255-261

Informa Healthcare

Access to resources Recommend Favorite

Darbepoetin alfa: a new approach to the treatment of chemotherapy-induced anaemia

By Vansteenkiste Johan   Rossi Gregory   Foote MaryAnn  

Expert Opinion on Biological Therapy, Vol. 3, Iss. 3, 2003-06 ,pp. : 501-508

Informa Healthcare

Access to resources Recommend Favorite

Eicosapentaenoic Acid Supplementation for Chronic Hepatitis C Patients During Combination Therapy of Pegylated Interferon α-2b and Ribavirin

By Kawashima Aiko  

Lipids, Vol. 43, Iss. 4, 2008-04 ,pp. : 325-333

Springer Publishing Company

Access to resources Recommend Favorite

Hepatitis C Virus Core Protein Potentiates TNF-α-Induced NF-κB Activation through TRAF2-IKKβ-Dependent Pathway

By Chung Y.M.   Park K.J.   Choi S.Y.   Hwang S.B.   Lee S.Y.  

Biochemical and Biophysical Research Communications, Vol. 284, Iss. 1, 2001-06 ,pp. : 15-19

Elsevier

Access to resources Recommend Favorite